Professional Documents
Culture Documents
N, O, L'L-:: Revenue Memorandum
N, O, L'L-:: Revenue Memorandum
January 2$.2i,t2il
SUBJECT : Publishing the Full Text of the January 3,2022Letter tr"rrn f i:ee Departnrent
of Health (DOH) Endorsing Updates to the List of \/4.'11'-n:h.ei'jnpt iJ0\r ID-
19 Medicines Under Republic Act (R.A.) No. 11534
For the information and guidance of all intemal revenue officers. ernploi,,--es aird otrers
concerned, attached is the letter dated January 3,2022 from Atty. Clhareide i:8. \4ercado -(iran<le.
Undersecretary of Health for the Health Regulation Team of tht: DOI-I, ,o: rh,: inclusio,r o1'
Molnupiravir 200 mg capsule under brand name Molnarz. Also attactr,:d is the colry ol' the
updated o'List of VAT-Bxempt Drugs and Vaccines Prescrihed arrrrr,l D;irectl1, [.l.srd 1[or
COVID-I9 Treatment" which includes the aforesaid medicine.
All concerned are hereby are enjoined to be guided accordingl.l, il.,ld 3,i.u,c thjs L'i,"cuiar
as w'ide a publicity as possible.
NTERNAL REVE
/F-+*../1$+1/
CAEIiAR It. iDtlLa'Y
r={?ft
.ii.'J It li Commissioner of In,rcrn ll iteven le:
m 049 4 5 s
.!Aij 3: 2tJ?:,1"
l\,^
,I
D
;- il oa
r"*-
r- i'1
(i
ot'.c\ (
TJSTOFVATGXEMPT DRUCSANDVACCINFS P* .9CRIBEDAND DII.f.TI.YI,SEI, tr(,B COVID r r, 1'l{l 4 I}If"llr
;A:-::- ":!;,.-----
It .: -l i'iirr:ii:i ;:iail
!A tl .;'1' tt'l I
JAt O .'- L"t.;-
t\: D{t oh,
r. r'i\/lsloN
D
IJST OF VAT EXEMTT DRUC€ A]t'D VACCTNEA PREIICRIBED ANI} OIR,E{,'II,Y U'9ND FOR 1](]r!,'Il) r t'tr{l I fr'lF $r i
r0 mg/EI. 10 mL
$ffil.;?;i;iff;;:--".
Fropofol
*:,8- - - ^-"-"*."-
Fnryrfo) 10 or&/m!,, 10 nrl, Soluti0o for lniection, Vial
for lnjetiun,
Pnqx,lol !0 m{,/ml, 20 mL
Fmtanr 2. , mc.r hr
rd
Foltrn'l
for Injr:1irtn,
I?ertmyl 50 mcly'mL, ro nL
lor Ir\ierlios
t entond 5o rnc/nrl, z mL
Modified Rr.len.* (lrlt)
Nlor1'hile r0 rng
uDr'f,binc
Solutior for Injection
loryrhifle !o mgJml-, r mL
Sr,lution f.{ lnjccti!n
!rarpbire 16 ore/$I- 1DL tunr$1r
au 4!. Tablct
'Ldss (]lRi
Morphinc 6o otg
O:'.rorIr to !r,i
let
iohrtion for lnj*iion,
)rl,codone ro mVmL r nL
rlution forllj*tion,
Drymdone 10 mglml. ? mL
()wrodone 26 $e!c4!s-{del-,
O.r.strlil)e :l,tele+._".C_Tlu*
.. rf!!l-q.-.-
P.....scrlo..$
lllacodone
....
-. -....-
tJ .'cdlone
0v0donc **-*
I Solution for lDj4tioo,
ADilecin m&/ml, 2 mt
lasrus-. -
Amilacin mrlmla 2 mL for rnietion, visl
---
lsolution
rz5 mglml+ z mL lsolutiotr for tnjffiion,
Amik*in l4!."llqlr,'
Amikrcitr E5 mB,/mL, 2 mL isolution for Injetion, fial
t-***"-. ,-. .. - --*-
,lmilacin 2so Eg/mI, 2 DL
I solution for
Injectiou,
-
l44ra!e--
Amilocin 25o nr/ml,,2 mL
----
Solution for ldjetion, Vial
lA;*t"ult" --
"
*":. !rm mc/ml. ro mL jO*c"r*;-r*l-.-
h-"d"lllt". Jree:rxrl,":'r.rr,"
- -- OEI $u,r,]leis|!&BI!_
P1-wttl-Y'J..19Jsl=-
Cruule
p-iE r}-tb"!9'rsh-le!, . ."
Rntlle
ord gure'n8ion" Bottle
{moxicillin . . .-
lr99m3 --..
fiq{ggqljj:a'-o-n-Agi
lCerrule ::---::
aF COR-Dai,-,: ii r,l i,,5'.
=.____ stoN
LIST OF VAT FXNM?T DRU{IS AHD VAC[INrj PNTSCRTBAI} AND I}IRECTI,Y T'.SAI
Aapboterieiu I {}loa-Upid
qg:\!te.\:-',. 50 DrE Powds, Yial
",^,. -.,..... -...... -..-.".
i
Alr:,icillin , Povdq. Yial
A,qrt'icilil". ioo .s{
fu:r-,Jlll-r !.!L*s"!nry -
&trjtprll.__E__ j.s-r,lb!j!.Bg}. zr+1.: vid_
Amricillin + srlhad'6
;0o vid
qELsu.$l_$si,otr, Botf e
O-!!1 f\tq !il",Elgtl 4.)tde
{zithmmrcin g4Lmrn'isl-l(, mL 0Bl Su6ffision, Bottle
EDrla
q?i1hrofr1r;n
io sul+
\zit!rcmrin 1'
{4,'I!A$jcin _._* iu)tlt"
Azilhremrcin
,..!.
Azilhmmrcia 100 --,- " "
lhfoiafinre
Ceftflidime lor,
Cefiqidise i2 t
oeftaidiure itoo m*
--mL -Solmi0n (X *-:
Ceftriuone
liL
lr + g 3.S 196
Vial i
C€Jtri&x{)De
irrlnj*tion,Yul
il.idmiog _ ]
JelumaD€ Pos,
:)funaur*-. !12q mg
gr-r4itiliLtig'q!.
Cehrmxime
:ii trrAl5ml",
;c--r
?o mL
Lleluronme 2t0 mr
Cefumdme li.aha
z-o et 1
2;o E*,/5 fi t- 50 mL
i
wr $urp.lrsm.lslM
Cefurprime Onl $uepqnsiun. Bottle
-
rcX*u --*----1 ?(ro ru
I
I
l
Cut
--------l ti'e-.-C"rBJ"d,&blS - :., -:" l,..,.
E fu!qrj",- .fio ltr!
r-efuroxime - ---_l-t i
Iirurf,r-"ir
:_.'--- tq _ .-*_^
I
I
r) fofloxmln lr ,_,- , I t_
I
-
Qi.luslgp"rq 1
I
!-l :vlololncin,
L\mfloxecin
fto
iro{loroon :ig-r!&- Plls-Cetdi Tablct
mglimL.2iml-
llariLlurr 2i mtr/t ml,. 1i nll
IaritlroEr:.l_q riIn i5rol...iomL
Ilaritlrcm r ci! l2tm]{1.!nl.60D-L
-'lrithmmr.in 12i, rul.,'q m!., 'o
3OO trlg Relee(PRl
.-,n*, - -
__
----a
mm\ cll
r.Lryl {)P VAtPXF.MPTDRUGS lNDvlOflNES PmTCRIBEI, Ar'If, DIRB(,ILY U$trl, I(}R c(1vll} rr IT{,i,1.1'h,I'Mr
i
fDrlhj6tl0n, 1 I
!
lg{ 20orl8 l
i
,.1 I
!
I
I
"'-' - - t'
I
j
'fablet
,Ii
qto mg + 615 mg/l.' trrl. too rtl Susy*rr,ion, Boltle
'l
---- f_-
n&/5 mL 60 EL
1
mg + 62.5 I
l
4oo m8 + 57 m8/5 nI. 30 nt! l
-l
I
4oo mg + 57 mg/5 m! 3g mt .--t.-
I
g?,v]rte!4!e),
m8 * 125m9
[3:silll .. -.". ... . .. ,
(irroxicillin r
"Anuicluv mg + re5 mg
f.{m-Cr*tel Tslrhl
t- - -
I
.' -.',i
i
1
I
.i
,-l
' .:
,i
{
--1
,'
I
1
'- -'1
!
i
- 'lI
-1
- ,...
J
i .'- i'
) ". . i.
REAU OF ilTE.RI.I
Jav
R irCORDS M(. r. filVlSl0l'i
r,rsT a)F vAT rxElrpl rrRtT(I9 At{D vA(IlrNES PRTSCnTRFIL ANn rrrRFcnx llsEn w)f,. cr .,rti}.r { ]'Rl .'t l' ll I rr t
ii"i : 'i 'r"
'*
for lqjection, Pe
rm mg {r0,o0s llD/ml. 0.6 ml'
',i
, -.'1
--i l
I
for Injoction, i
I
20 IU/'nI4 1rrl,
I
I
I
i
1
I
!
1
j
_i i
l
" -1
,j
hffrhr*.raar.DUq 1
,..+r4@r:d/ulR 1- i
irrvir (Artnd: l'tolnr.'l '1 I
l
5 mglml.2l) mL Solrrtion {or Injection. f ial
-
'rl,-'l
.t
I
I
frrr lrrjeclion,
2i mg/mI-. ro mL 'I
D()piminr
N]frr
Dopaininr in tX DeatroJe , tlll +',
lj il\\
J. r."1 d --
iflc in 5X Dertrcse
tHlt;t"l
tl,lJ-l- V ,- J,]!l
L! anRt'tc lirl I !al\/l tr{,)N
*'-, .".-i
I.ISI'OF VAT IXEMPT DRUGS AITID VACCINES PnEgCn[tED AJVD DIf,-ECTLY USBI, FOn CCr4]] 1 r trftn: t'I ti I I'lt
I
rlitf & Ir ,{.:,'! ,.'iir!
.-- .".- l
llDlr'ilir.ld
[ .,,,i, "i . iz,r iiii- -- -" -"-- lsr
'Io,,is.i,.
n,,rtr.* -
lJri, il1iaiF I tr}. ml, 6il trrl. j?iil;;li"iri"--
lp_ tlt-!r,jlt!. r ?_u_p_L
9nl $r,rr! Brttle _*
rrnr .0 !i. . fiL 60 ml, (l..il !iii,t, li,,l't
77WW&W **---i*-t-
Solutioo for InJedion, ir
fut!drrul l{te-rd 14 B(g pre.filled ;rt lrim
lr:r jrftr,_ rd. $tt " "..-... "l . )"
i
till
_* '_'- '] _'_ 1- - '
I (rDi : I alun 2ooAcluali.ros Ivlele.rg!_l&le_.blghr__
I
i
toD nrcF + 6 IxE,/actuatioo, l?i., i
lolr(,thasaqr + Folrilot?erl MeJcrcd Dosr hhaler
Aruatiofls
il
I
ti
{chulions Metexl I)6c lrllrolr
tsExlonlethaEo[e + l,bmot?rol + rOO n1'18 + 6 hc8 + 10 m.Pjnctn0tlon
1?oAfrrsdonr
i rsctu6li0i 2of, Actuali()ns
204, rtu
Metertd l)ost Inhaler
M"1".*l n**Jr ;
.--i-'1"
lt
Eudesonide
:htirasone
Irlufifa!(nxr I Fl)fitrulcml
200 nctr actuation rooAdurrionr
r25 nrcg +
Aetuations
S mcg/sctualion, 120
Metered Do6c
Iletord
lahr
Ilc,trrel fjose I
Dorir lrhaler
,,r1"
1t
il
FluLicsu[e + Frrfi[olefi, io rict + 5 mrg/actuation, l2o
l{elrred Dr;sc lnhalcr 1i
Fluli(uque + Salnrcttroi
{ctDAti0ns
12S ncg a 2j mcg/acfution. 120
tiI: 1l
li
r\rt trnti rtrr s
:".r,ri l:t.
il
h hrtjragnr: i $almcterrri
f'luliqsonc i .lhlttrcri:r0i
l5o 81fg + ?5 s.Prlarh'ali()n, !?()
ALtBations
5o mcg + r"5 mc.g,/actuatior,
Actuafion*
rro
Mererrrl l)o-re fnhakl
lnfuJiou, lla,
-i-j- '_-,l
Acctaled itingcr's
A(etatcd Rirgci
L 8o\rtion lirr lrrir:ction
lnfu6ir)r, lhttle
S<rlution for hrjr*tion
/
/ tl ti
i
I
ii
So0 rnl,
Infugion, B,f ti I
lr-
i00 rBL
ln(usion- Iloltle I
Balancrrl Mrltiplc itlriDtcron{r Sohrtion firr lnir,'ction / ---t
Solutirn + ;.q f)ext.ose rL t
,ioo slL i I
IJ&t!!l s'rr.|}!lntse tnflriion ltnnlc ;
I
B{ioued llrrliiple Sepl&re$ent Soh,tionl0r,nicction,/ J
1.
lirnr5,ioIr. tia.r_*._ .* J l
Ralarcrd ultiPlc Retlla.emcnt
I
IVI
L S<rluti<n frrr lnjectir,n / |
krlulion .% I)c(rora Infusion- Bottle I
I
I {
:"",,
tI1y !0'X, r L Solutioo forlnjetion
Inl'usion, tsn,,
/ i
_ i
lnfusiot. Ilotlle I
,i
in lt'ater iolution firr lojcctioB,l
s%,tl lnfusion. Ba;; i
!
i Infu(ion. lri{
G,,r.;;;i;;""i";7--T
|
I V, - Jr'irl .J .- r;t-t-
t
0mt
ilil
lur8er'i .,)H l|lxtr)rc
La(laLed I L
lilfir(inn- ll.nth I ,9: @
,(:tatdl lulger'b + 5X ilextror! ML
SDhtioD forlnje(ion I
lnfurion,Iln{ JJUi.l 5VJKT_V_]
trr:trtr\l Ringer's r. 5% D€ytrose ) )nL
for Ynjection ,/ RE uoRDs-Mc-l;ntvt rfN' -
-l!/ltk*--.*
i(ia1&l 11ir1! rir Sgliiion 1
frrrfnjr:r:tion /
rJly[o$ vATEXEMPT DBUCS AIIDVACCTNES pBISCnI.BEDAIID DInECTLA USED FORCO"{n r' lRr',t1MT
'
S{rlution l0r Ir{6tjofi /
I ic.trled lli ngo's tlrlution L 0ottlc
Sohtila lirr lnjmtirru /
ictaled Itirt8qr'! S.trliolr ioo mL
Johttion lor Irjeclien /
lrcirl{YI Ri nlcr's lolnlioti ioo il1, lnfdsion. Blttle
rr for lnjection /
rf,JiuIr + Der*dri! :).3x,+5'{,r1.
lDltrtiot ir)r ltr_ief,li(trr I
iftli$nr i Deil.rGtif 0.3!r f 5%, 1L
!fu.njgl,tl.ottlj__
iolutjon for lnjection /
kx.lhrnr + I)extrfise iJt( r iX.5oo ml.
i[rryil2:r,. Ui.:.--.
loludon --.-.*
tor Inieclion /
iodiulu + D$tluc .3% r 5X, f,oo Nl- 'nfirsioa- Retlit:
tulution for lnje{tioD I
krdiu$ r lle\tis( -45% ' 11.
"r%, i -- **
lolution forfujetittn / t
r 5!(. 1L
iolufo0 rur lDjediun /
ir!)ium r Dslilxi0 0.996
Baticitinih
U+bls.*
,ir;nih
12o m#ml,, 11.r rL vial + r2o
iolution fur Infusiotr. Box r'r l,J('/aiIl'r,I :r)21
)usiririmab + tm(lrvimsb
'-. *r ,r r rnl 1,ir1
rr.rt m61mL,, a.5 ml.,!ial -r tttl for lflflsion. Box I bit"bl llhtlliL" .iilsi:itir v t., I'i v|lrl,er,,)2 t
)relrivimab r Imdeimab
I
IT I )JIL-,,?J-E-L-!EL-*-- -
rronlimdb
sokltrrn for lnioctiqn, Pre
fwiliuuBat) r6r roL/{}.g [il4 o.q rnl.,
k!U,llietlIresfiD**
,r,l i rrr 4!r1{rk!
for lqietlioo,
)ffimethNne 2 m8/ml 2 mL tsUR AU OF INTERNAL FE' /EhtilI
I n\- 4,rr\J L*r] T7E:+ VT
F..-+r-JtB!rulJa
$olurion for lnjmtion, I
ttrl
lflmethMne m&/ml 1mL for Injction.Vial i
{li\
mB/m14 2 mL
[\\ tr.rcrTG,:rrfffi--Tl '.A 1U
mE/ml. 2 oL fortrrjection, VirI 1
F OSRD$ MGT. DIVISION
5 loB,/sl4 lnll
nrml. rooml
IIST OFVA'I'EXEMTTDRUGS ANDVACCINES PRXSCruEEDAND DIf,,EI]TLYUSEI} FOE.(X 'r-ll) r I 'l'lill.l l]\l l.l.l f
Crnrric \ure I "'i--'*" '":, ;;;:::'" - '-i i
$tr ii;.;.iii
oermethen€ j5o urg/lr! r orl- for InJetlon,
I (It!/ml, 10
I
r]L
I
\ fr?Jfi|.2 ml,
, rn&'|ml-.1 DL
: mglu [,, .1 nr l,
mr
t_[\jbl'
t<r' 1,rGJ', DlVlSiifN